The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
AC Immune SA
NASDAQ:ACIU
|
CH |
|
Owens Corning
NYSE:OC
|
US |
|
Crane Co
F:T12
|
US |
|
Grupo Aeroportuario del Centro Norte SAB De CV
NASDAQ:OMAB
|
MX |
|
Vulcan Minerals Inc
F:VM3
|
CA |
|
M
|
Mobase Co Ltd
KOSDAQ:101330
|
KR |
|
Beneteau SA
OTC:BTEAF
|
FR |
|
C
|
Cannabix Technologies Inc
CNSX:BLO
|
CA |
|
Lagardere SA
PAR:MMB
|
FR |
|
P
|
Panasonic Holdings Corp
XHAM:MAT1
|
JP |
|
A
|
ABC SA
SGO:ABC
|
CL |
|
C
|
Computacenter PLC
SWB:COUD
|
UK |
|
A
|
APTIV PLC
F:D7A
|
CH |
|
K
|
Kering SA
SWB:PPX
|
FR |
|
N
|
Nordic American Tanker Ltd
F:B3O
|
BM |
|
E
|
Exco Technologies Ltd
TSX:XTC
|
CA |
|
C
|
Calgro M3 Holdings Ltd
JSE:CGR
|
ZA |
|
G
|
GEA Group AG
SWB:G1A
|
DE |
|
T
|
Teledyne Technologies Inc
F:TYZ
|
US |
|
R
|
Rush Enterprises Inc
F:RUNA
|
US |
AC Immune SA (ACIU)’s 12-month stock price forecast through October 2027 has a consensus target of $10.14, implying 357% upside. The forecast is based on price targets from 5 Wall Street analysts.
Past growth per year Not enough data
Average annual growth cannot be calculated for these periods.
Explore analyst estimates, growth and forecast ranges.
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
According to Wall Street analysts, the average 1-year price target for
ACIU is 10.14 USD with a low forecast of 5.45 USD and a high forecast of 12.6 USD.
Over the last 11 years, the compound annual growth rate for Revenue has been -18%. The projected CAGR for the next 5 years is 87%.
We rebuilt our DCF valuation models from the ground up and upgraded how Intrinsic Value is calculated. Alpha Spread now selects the method that best fits each company.
You can now see how the new methodology performed across thousands of stocks on our new Valuation Backtest page. We update the results at the end of every month.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
Stock intrinsic value is the real worth of a company's stock, based on its financial health and performance.
Instead of looking at the stock's current market price, which can change due to people's opinions and emotions, intrinsic value helps us understand if a stock is truly a good deal or not.
By focusing on the company's actual financial strength, like its earnings and debts, we can make better decisions about which stocks to buy and when.
Read more